INM - InMed Pharmaceuticals Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/22/2023
Current
3/31/202312/31/20229/30/20226/30/20223/31/2022
Market Cap (intraday)
4.56M3.59M3.21M5.99M7.65M13.47M
Enterprise Value
-6.34M-7.30M-5.44M564.23k2.63M3.19M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
0.930.730.943.399.8336.82
Price/Book (mrq)
0.320.250.290.660.700.95
Enterprise Value/Revenue
-2.71-7.06-11.581.765.1110.30
Enterprise Value/EBITDA
0.423.652.49-0.17-0.34-0.96

Yahoo Finance Plus Essential access required.

Learn more

Trading Information

Stock Price History

Beta (5Y Monthly) 1.06
52-Week Change 3-93.40%
S&P500 52-Week Change 31.77%
52 Week High 319.9750
52 Week Low 30.9210
50-Day Moving Average 31.2457
200-Day Moving Average 33.3090

Share Statistics

Avg Vol (3 month) 3623.33k
Avg Vol (10 day) 3174.83k
Shares Outstanding 53.33M
Implied Shares Outstanding 6N/A
Float 83.31M
% Held by Insiders 10.15%
% Held by Institutions 13.48%
Shares Short (May 14, 2023) 464.88k
Short Ratio (May 14, 2023) 40.46
Short % of Float (May 14, 2023) 41.96%
Short % of Shares Outstanding (May 14, 2023) 41.95%
Shares Short (prior month Apr 13, 2023) 4126.3k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 05, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Sep 06, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 29, 2022
Most Recent Quarter (mrq)Mar 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-457.83%

Management Effectiveness

Return on Assets (ttm)-44.31%
Return on Equity (ttm)-133.02%

Income Statement

Revenue (ttm)2.34M
Revenue Per Share (ttm)1.32
Quarterly Revenue Growth (yoy)234.00%
Gross Profit (ttm)543.55k
EBITDA -10.51M
Net Income Avi to Common (ttm)-15.48M
Diluted EPS (ttm)-16.4400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.65M
Total Cash Per Share (mrq)2.9
Total Debt (mrq)496.37k
Total Debt/Equity (mrq)4.01
Current Ratio (mrq)5.22
Book Value Per Share (mrq)3.72

Cash Flow Statement

Operating Cash Flow (ttm)-10.67M
Levered Free Cash Flow (ttm)-7.03M